Resistance to activated protein c in patients with venous leg ulcers

Dermatology

Volumn 195, Issue 4, 1997, Pages 413-414

  Hafiier, J ^a   Von Felten, A ^b  

^a Department of Dermatology and Division of Haemostasise ^*  (Switzerland)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Deep vein thrombosis; Postthrombotic syndrome; Resistance to activated protein C (APC); Venous leg ulcer

Indexed keywords

ACTIVATED PROTEIN C;

ACTIVATED PROTEIN C RESISTANCE; CLINICAL ARTICLE; HUMAN; LEG ULCER; LETTER; PRIORITY JOURNAL;

DRUG RESISTANCE; ENZYME ACTIVATION; HUMANS; PILOT PROJECTS; POSTPHLEBITIC SYNDROME; PREVALENCE; PROTEIN C; PROTHROMBIN TIME; PULMONARY EMBOLISM; THROMBOPHLEBITIS; ULTRASONOGRAPHY, DOPPLER; VARICOSE ULCER;

EID: 0031472653     PISSN: 10188665     EISSN: 14219832     Source Type: Journal    
DOI: 10.1159/000246006     Document Type: Article

References (7)

1. Benina RM. Koeleman BPC. Koster T. Rosendaal FR. Dirven RJ. de Ronde H. van der Velden PA. Rcitsma PH: Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369:64-67.
2. Koster T. Rosendaal FR. de Ronde H. Brict E. Vandenbroucke JP. Benina RM: Venous thrombosis due to poor anticoagulant response to activated protein C: Leiden thrombophilia study. Lancet 1993:342:1503-1506.
3. Dcsmarais S, de Moerloose P. Reber G, Minazio P. Perrier A. Bounameaux H: Resistance to activated protein C in an unselected population of patients with pulmonary embolism. Lancet 1996:347:1374-1375.
4. Munkvad S. Jorgensen M: Resistance to activated protein C: A common anticoagulant deficiency in patients with venous leg ulceration. Br J Dermatol 1996:134:296-298.
5. Hal'ner J. Bounameaux H. Burg G. Brunner U: Management of venous leg ulcers. Vasa 1996:25:161-167.
6. de Ronde H. Benina RM: Laboratory diagnosis of A PC resistance: A critical evaluation of the test and the development of diagnostic criteria. Thromb Haemost 1994:72:880-886.
7. Bertina RM. Reitsma PH. Rosendaal PR. Vandenbroucke JP: Resistance to activated protein C and factor V Leiden as risk factors for venous thrombosis. Thromb Haemost 1995:74:449-453.